Medicare EpiPen spending outpaces prescription growth -Kaiser report

September 20, 2016 7:20 PM

14 0

NEW YORK, Sept 20 U.S. government spending on Mylan Inc's EpiPen in the Medicare program for seniors and the disabled rose 1,151 percent from 2007 through 2014, while the number of EpiPen users grew 164 percent, the Kaiser Family Foundation said on Tuesday in an analysis.

The spending figure excludes after-market manufacturer rebates that Mylan paid to the private insurers who manage the Medicare Part D program for pharmacy drugs on behalf of the government, it said.

Read more

To category page